Sagimet Biosciences Inc. Series A Common Stock (SGMT)
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a 13-report earnings history dating back to Aug 21, 2023. Its average absolute post-earnings move is ±10.30%, and 46.2% of those reactions were positive. Its largest post-earnings gain was +39.01% (Apr 27, 2026) and its largest decline was -14.38% (Nov 14, 2024). The next earnings report is predicted for 2026-08-14 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±10.30%
Positive %
46.2%
Negative %
53.8%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☀ PRE | $7.67 | $7.67 | $7.64 | 50,978 | -0.65% | open_in_new |
| Apr 27, 2026 | ☀ PRE | $7.22 | $9.36 | $8.16 | 604,004 | +39.01% | open_in_new |
| Mar 11, 2026 | ☀ PRE | $5.82 | $5.89 | $5.74 | 19,045 | +3.89% | open_in_new |
| Nov 13, 2025 | ☀ PRE | $8.02 | $8.35 | $7.78 | 52,674 | -11.95% | open_in_new |
| Aug 13, 2025 | ☀ PRE | $9.83 | $10.03 | $9.59 | 20,005 | +0.95% | open_in_new |
| May 08, 2025 | ☀ PRE | $3.39 | $3.42 | $3.19 | 15,756 | -4.78% | open_in_new |
| Mar 12, 2025 | ☀ PRE | $3.46 | $3.54 | $3.52 | 8,330 | +3.83% | open_in_new |
| Nov 14, 2024 | ☀ PRE | $5.74 | $5.85 | $5.18 | 39,677 | -14.38% | open_in_new |
| Aug 14, 2024 | ☀ PRE | $2.74 | $2.78 | $2.48 | 16,812 | -6.75% | open_in_new |
| May 15, 2024 | ☀ PRE | $4.63 | $4.70 | $4.64 | 7,641 | +6.3% | open_in_new |
| Mar 25, 2024 | ☀ PRE | $4.92 | $5.68 | $5.24 | 20,136 | +16.32% | open_in_new |
| Nov 13, 2023 | ☀ PRE | $2.64 | $2.67 | $2.24 | 5,338 | -12.16% | open_in_new |
| Aug 21, 2023 | ☽ POST | $12.71 | $12.75 | $12.25 | 8,103 | -12.9% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±10.30%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
7 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260603 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 4 | 20260601 | open_in_new SEC.gov |
| 3 | 20260514 | open_in_new SEC.gov |
| 4 | 20260514 | open_in_new SEC.gov |
Frequently asked about SGMT earnings
When does Sagimet Biosciences Inc. Series A Common Stock report earnings next? expand_more
Sagimet Biosciences Inc. Series A Common Stock (SGMT)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SGMT stock move after earnings? expand_more
Over 13 reports, SGMT has moved an average of ±10.30% the session after earnings, closing higher 46.2% of the time.
What was SGMT's biggest post-earnings move? expand_more
SGMT's largest post-earnings gain on record was +39.01% on Apr 27, 2026, and its largest decline was -14.38% on Nov 14, 2024.
Where can I find Sagimet Biosciences Inc. Series A Common Stock's SEC filings? expand_more
All of Sagimet Biosciences Inc. Series A Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right